Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload Patients With β-Thalassemia and Intermediate Thalassemia in Bandarabbas

NCT01369719 is registered in ClinicalTrials.gov with Hormozgan University of Medical Sciences as lead sponsor.

NCT NCT01369719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01369719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload Patients With β-Thalassemia and Intermediate Thalassemia in Bandarabbas
Lead sponsor
Hormozgan University of Medical Sciences
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2010
Completion date
May 31, 2011
Enrollment
138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron overload, thalassemia, transfusion related complications